Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin implants and long daylight hours alter the timing of hormone release and hair growth in mouflon sheep.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Giant pituitary macroadenomas causing Cushing disease are rare and may need extra treatment if surgery fails.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

High prolactin and low vitamin D levels may be linked to hair loss in women.

Hormonal imbalances, including high prolactin and thyroid issues, contribute to hair growth problems in women.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Middle-aged men with unusual hot flashes should be checked for pituitary tumors.

Latanoprost, a glaucoma drug, showed potential for promoting hair growth in bald monkeys, especially at higher doses.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

A woman's hair grew back after she stopped taking the Parkinson's disease medication pramipexole.

A rare case of Cushing's syndrome and pheochromocytoma requires careful re-evaluation to avoid complications.

Prolactin levels do not control the start of winter fur growth in mink.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

PRP injection for hair growth can cause reversible vision loss due to inflammatory optic neuropathy.